Historical shareholding details of Antariksha Securities p. Ltd holdings in Sterling Biotech Ltd. (STERLINBIO)

Quarterly changes of Antariksha Securities p. Ltd shareholding in Sterling Biotech Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Dec 2020 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Sep 2020 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Jun 2020 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Mar 2020 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Dec 2019 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Sep 2019 Antariksha Securities Pvt Ltd 1,950,000 0.72% 1,950,000 100.00% 0 0.00%
Jun 2019 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Mar 2019 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Dec 2018 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Sep 2018 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Jun 2018 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Mar 2018 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Dec 2017 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Sep 2017 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Jun 2017 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Mar 2017 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Dec 2016 Antariksha Securities Pvt Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Sep 2016 Antariksha Securities P. Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Jun 2016 Antariksha Securities P. Ltd 1,950,000 0.79% 1,950,000 100.00% 0 0.00%
Mar 2016 Antariksha Securities P. Ltd. 1,950,000 0.81% 1,950,000 100.00% 0 0.00%
Dec 2015 Antariksha Securities P. Ltd. 1,950,000 0.81% 1,950,000 100.00% 0 0.00%

View all shareholdings details of Sterling Biotech Ltd.